New sensor could spot pregnancy diabetes sooner, protect moms and babies
NCT ID NCT05430204
Summary
This study tested whether using a continuous glucose monitor (CGM) to screen for gestational diabetes works better than the usual one-time blood test. It involved over 1,600 pregnant women between 24-30 weeks. The goal was to see if the CGM method leads to fewer health problems for mothers and newborns and lowers overall healthcare costs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.